Neogenetix Biopharma

Neogenetix Biopharma (NGXX) is a precision health biotechnology company at the forefront of microbiome science, genomics, and AI-driven health innovation. Our Mission: To decode the gut microbiome - the body's command center for immunity, metabolism, and mental wellness - and translate breakthrough science into accessible, life-changing solutions. What We Do: We combine cutting-edge bioinformatics, machine learning, and clinical research to unlock the hidden language of the microbiome. Our work spans three pillars: Research & Development – Pioneering gut-health innovations rooted in genomic and metagenomic analysis Consumer Health – Delivering science-backed products through brands like Simpli Supplemented Clinical & Industry Partnerships – Empowering healthcare providers and researchers with next-generation diagnostic and therapeutic tools Why the Gut? The gut microbiome influences 70% of immune function, regulates neurotransmitters, and acts as a gatekeeper to systemic health. We're building the future where personalized, predictive healthcare begins in the gut. Our Vision: A world where health isn't reactive- it's personalized, preventive, and powered by the trillions of microbes within us. Whether you're a researcher, clinician, investor, or someone seeking better health, Neogenetix is bridging the gap between lab discoveries and real-world impact.